Lastname Organization Clinical Trials State / Region Country
Dubravka Dodig
Clinical Evaluator
University Health Network Canada
Erin DeSpain University of Utah Arimoclomo (ends 2017), FOR-DMD (ends 2024), CMT (ends 2017) Utah United States
William David
Principal Investigator
Massachusetts General Hospital, Harvard Medical School Methotrexa (ends 2019) Massachusetts United States
Emma Ciafaloni
Executive Committee
Principal Investigator
University of Rochester Arimoclomo (ends 2017), FOR-DMD (ends 2024), HYPHOP (ends 2018), n/a New York United States
Tobin Chettiath
Principal Investigator
Ultragenyx Pharmaceutical California United States
Bryan Burnette
Principal Investigator
Vanderbilt University Medical Center FOR-DMD (ends 2024) Tennessee United States
Deborah Bradshaw
Principal Investigator
SUNY Upstate Medical University New York United States
Michael Benatar
Executive Committee
Principal Investigator
University of Miami EPITOME I (ends 2018), Methotrexa (ends 2019), n/a Florida United States
Yaacov Anziska
Principal Investigator
SUNY-Downstate Medical Center FOR-DMD (ends 2024) New York United States

Select a Country

Select a Country

Select a Country

Select a Country

Select a Country